PharmiWeb

2026 Payer IT Outsourcing Outlook: Outcome-Based Managed Services, Production-Grade GenAI Governance, and Vendor-Risk Enforcement

Black Book Research Q4 flash survey shows health plans shifting from effort-based sourcing to KPI-backed operating models, tightening third- and fourth-party controls while accelerating platform and ...
PharmiWeb

Cosmos Health Is Building a Platform, and Tariffs Are Accelerating the Strategy

CHICAGO, IL / ACCESS Newswire / December 24, 2025 / Healthcare investors have seen this movie before. A company leans hard on a single product, rides momentum while it lasts, then scrambles when ...
PharmiWeb

Dermata Therapeutics Announces up to $12.4 Million Private Placement Priced At-The-Market Under Nasdaq Rules

SAN DIEGO, CA / ACCESS Newswire / December 24, 2025 / Dermata Therapeutics, Inc. (NASDAQ:DRMA)(NASDAQ:DRMAW) ("Dermata," or the "Company"), ...
PharmiWeb

Peer-Reviewed Studies Validate Linus Health AI as an Early Digital Biomarker for Alzheimer’s Pathology, Helping People Take Action Earlier to Slow Disease Impact

Findings show Linus Health’s AI can indicate Alzheimer’s pathology before noticeable symptoms—enabling earlier action to help protect independence and preserve what makes us who we areBOSTON, December ...
PharmiWeb

Bausch Health Announces Final Results and Expiration of Exchange Offers

LAVAL, QC / ACCESS Newswire / December 23, 2025 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) (the "Company") and its subsidiary 1261229 B.C. Ltd. (the "Issuer" and, together with the Company, ...
PharmiWeb

CASI Pharmaceuticals Receives Extension from Nasdaq to Meet Listing Requirements

SOUTH SAN FRANCISCO, CALIFORNIA / ACCESS Newswire / December 23, 2025 / CASI Pharmaceuticals, Inc. (NASDAQ:CASI), a clinical-stage biopharmaceutical company focused on developing CID-103, a potential ...
PharmiWeb

Samsung Biologics buys GSK’s Human Genome Sciences unit to expand US biologics manufacturing

Samsung Biologics has agreed to acquire GlaxoSmithKline’s Human Genome Sciences and its two pharmaceutical manufacturing ...
PharmiWeb

Hansa Biopharma Submits BLA to FDA for Imlifidase in desensitization for Kidney Transplantation

Hansa Biopharma Submits BLA to FDA for Imlifidase in desensitization for Kidney TransplantationThe application is based on the successful outcome of the pivotal US Phase 3 ConfIdeS trial in highly ...
PharmiWeb

Ondine and Mid Yorkshire Teaching NHS Trust shortlisted for Excellence in Healthcare Partnership Award for Reducing Surgical Site Infections with Nasal Photodisinfection

Ondine and Mid Yorkshire Teaching NHS Trust shortlisted for Excellence in Healthcare Partnership Award for Reducing Surgical Site Infections with Nasal Photodisinfection Second national award ...
PharmiWeb

IFAD and the GEF announce three climate-resilience investments in rural people in Eritrea, Kiribati and Malawi

IFAD and the GEF announce three climate-resilience investments in rural people in Eritrea, Kiribati and MalawiRome, 22 December 2025. The International Fund for Agricultural Development (IFAD), in ...
PharmiWeb

Absorbable Sutures Market Report Predictions by Global Market Trends, Future Growth, Regional Overview and Forecast Outlook until 2031

Global Absorbable Sutures Market OverviewThe global absorbable sutures market is projected to grow at a steady rate of around 5% over the next five years, supported by the increasing number of ...
PharmiWeb

Orthobiologics Market Research Report, Analysis, Size, Share, Growth by Forecast to 2026

The global Orthobiologics Market, valued at $5.4 billion in 2021, is expected to grow at a rate of 7% annually through 2026. This growth is driven by factors such as an increasing number of sports ...